Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141859 |
| CAS No | NA |
| Mol.F. | C14H20FN5O7 |
| Mol.Wt. | 389.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141860 |
| CAS No | 38652-29-8 |
| Mol.F. | C14H10N2O |
| Mol.Wt. | 222.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141861 |
| CAS No | 7458-08-4 |
| Mol.F. | C14H12N2O |
| Mol.Wt. | 224.3 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141862 |
| CAS No | NA |
| Mol.F. | C15H16ClN3O2 |
| Mol.Wt. | 305.8 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141863 |
| CAS No | NA |
| Mol.F. | C16H23N3O4 |
| Mol.Wt. | 321.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141864 |
| CAS No | NA |
| Mol.F. | C14H30N2O6 |
| Mol.Wt. | 322.40 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141865 |
| CAS No | NA |
| Mol.F. | C16H20N2O4 |
| Mol.Wt. | 304.25 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141866 |
| CAS No | NA |
| Mol.F. | C16H18N2O5 |
| Mol.Wt. | 318.33 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141867 |
| CAS No | NA |
| Mol.F. | C19H21N3O |
| Mol.Wt. | 307.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141868 |
| CAS No | NA |
| Mol.F. | C17H17N3O3 |
| Mol.Wt. | 311.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141869 |
| CAS No | NA |
| Mol.F. | C14H13N3O2 |
| Mol.Wt. | 255.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141870 |
| CAS No | NA |
| Mol.F. | C30H35N5O4 |
| Mol.Wt. | 529.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141871 |
| CAS No | NA |
| Mol.F. | C30H33N5O4 |
| Mol.Wt. | 527.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141872 |
| CAS No | NA |
| Mol.F. | C13H13N3O4 |
| Mol.Wt. | 275.3 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0141873 |
| CAS No | 18600-49-2 |
| Mol.F. | C9H10N2O3 |
| Mol.Wt. | 194.19 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141874 |
| CAS No | NA |
| Mol.F. | C25H26IN3O3 |
| Mol.Wt. | 543.4 |
| INV STATUS | In Stock |